Rockefeller Capital Management
IMCR icon

Rockefeller Capital Management’s Immunocore IMCR Stock Holding History

Rockefeller Capital Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$241 Sell
8
-1,351
-99% -$43.7K ﹤0.01% 4595
2025
Q4 		$47.2K Buy
+1,359
New +$48K ﹤0.01% 3098
2023
Q1 		– Sell
-165
Closed -$9K – 2907
2022
Q4 		$9K Buy
+165
New +$9.29K ﹤0.01% 3122
2022
Q1 		– Sell
-1,000
Closed -$34K – 3964
2021
Q4 		$34K Buy
+1,000
New +$36.2K ﹤0.01% 2383

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Rockefeller Capital Management's IMCR Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Immunocore (IMCR) stake by 99% in Q1 2026, selling an estimated $43.7K and leaving 8 shares worth $241. The position accounts for ﹤0.01% of the portfolio, ranked #4595.

Rockefeller Capital Management first reported a position in IMCR in Q4 2021 and has held it in 4 quarters since. The position peaked at $47.2K in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Rockefeller Capital Management held 8 shares of Immunocore worth $241 as of Q1 2026.
  • Rockefeller Capital Management sold 1,351 Immunocore shares in Q1 2026, an estimated $43.7K.
  • Immunocore made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4595 holding.
  • Rockefeller Capital Management first reported a position in Immunocore in Q4 2021 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Immunocore position peaked at $47.2K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.